The State of Frontier Neuroscience: This is the century of the brain.
Why now, what’s investable & who wins.
External link. We are not responsible for the content.
Read more ↗More From PsyMed Ventures
Brain Organoids: from Space to AI with Alysson Muotri
Professor Alysson R. Muotri (geneticist and developmental biologist at UC San Diego) joins for a far out conversation...
Digital Addiction: The Investment Landscape + What Wins Now
The first thing many of us touch in the morning is a screen. Checking notifications quickly turns into a scroll, the ...
How Gilgamesh Landed a $1.2B AbbVie Deal in Psychedelics
Jonathan Sporn (CEO + Founder of Gilgamesh Pharma) joins for a deep dive into next-gen psychedelic medicines, why dur...
Latest News
Synthetic Psilocybin Doesn’t Produce the Entourage Effect
The effects of full-spectrum psilocybin could have implications for the future of psilocybin-assisted therapy. [...] ...
Protected: MAPS Publishes Ibogaine Investigator’s Brochure as a Free, Open-Access Resource
There is no excerpt because this is a protected post.
Approval Is Not Access: A Postcard From Psychedelic Europe
At ICPR 2026 at the historic city ofin Haarlem in the Netherlands, the companies racing to turn psychedelics into app...
Psychedelic Policy Briefing: Week of June 29nd, 2026
Massachusetts advances two psychedelic therapy pilot bills, Louisiana's opioid-settlement-funded program takes effect...
A Country That Recalls Its Own Forgetting
Between the 1930s and 1960s, Italian clinics ran psychedelic experiments on hundreds of patients, then forgot they ev...
Do psychedelics create false memories? 5 Questions with psychologist Samuli Kangaslampi
Kangaslampi discusses the need to study autobiographical memories that may emerge during trips.